Glanbia plc, the Irish-headquartered global nutrition and cheese ingredients group, has announced that its 2027 Annual General Meeting will be held on Wednesday, 28 April 2027. The disclosure was made via a regulatory announcement dated 20 November 2026, giving shareholders early notice of the forthcoming meeting date. For investors tracking corporate governance timelines, the confirmation of the AGM date is a routine but important calendar milestone ahead of the new financial year.

Key Points

  • Glanbia plc (GLB) — Irish-headquartered global nutrition and cheese ingredients company
  • Glanbia has confirmed its 2027 Annual General Meeting will be held on Wednesday, 28 April 2027
  • The announcement was published on 20 November 2026; no further details of the AGM agenda were disclosed
  • Investors should watch for the formal Notice of AGM, which will set out resolutions and voting items ahead of the April meeting

Glanbia plc Confirms 28 April 2027 as Its Annual General Meeting Date

Glanbia plc announced on 20 November 2026 that its 2027 Annual General Meeting will take place on Wednesday, 28 April 2027. The company did not disclose the venue, format, or agenda items in this initial announcement. For a business of Glanbia's scale — operating across global performance nutrition brands and cheese ingredients — the AGM represents a key governance event at which shareholders typically vote on board appointments, executive remuneration, and the adoption of annual financial statements. The early publication of the date allows institutional and retail shareholders to plan their attendance and proxy voting accordingly.

What Glanbia's AGM Calendar Disclosure Means for Shareholders

The release of the AGM date several months in advance reflects standard Irish and UK corporate governance practice, giving shareholders sufficient notice under company law requirements. Glanbia is listed and subject to ongoing regulatory disclosure obligations, making timely communication of meeting dates a compliance matter as well as an investor relations courtesy. The company did not disclose resolutions, board proposals, or any special business expected to be tabled at the April 2027 meeting. Shareholders seeking further detail will need to await the formal Notice of AGM, which is typically published closer to the meeting date.

Glanbia's Position as a Global Nutrition and Ingredients Business

Glanbia operates as one of the world's leading nutrition companies, with interests spanning performance nutrition products and cheese and dairy ingredients. The group generates revenue through branded consumer-facing nutrition products as well as business-to-business ingredients supply chains, giving it exposure to both consumer spending trends and global dairy commodity markets. These dual revenue streams mean the AGM is likely to attract scrutiny on strategic direction, capital allocation, and management performance from a diverse shareholder base. The company did not disclose any financial metrics or guidance updates in connection with this announcement.